Int J Pediatr Otorhinolaryngol
Diagnosis, DifferentialMucocutaneous Lymph Node SyndromeRetropharyngeal Abscess
Dr. Mark R. Homicz, MD
NPI1336198449PAC ID0143295378
- Medicare services, 2024
- 1,515
- Medicare patients, 2024
- 509
- Part D claims, 2024
- 406
- Publications
- 6
- MIPS score, 2024
- 81
- Practice address
- 1701 4th St, Santa Rosa, CA 95404
- Practice phone
- Call (415) 884-1840
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Prima Medical Foundation
Santa Rosa, California
Find Dr. Homicz's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark R. Homicz is an otolaryngologist in Santa Rosa, California
Dr. Homicz practices at Prima Medical Foundation in Santa Rosa, California.
Dr. Homicz's NPI, 1336198449, was assigned on May 8, 2006. Dr. Homicz graduated from Yale School of Medicine in 1998. Dr. Homicz holds California license A70413.
NPI and contact details
- NPI
- 1336198449NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0143295378
- NPI enumeration date
- May 8, 2006
- NPI status
- Active
- Offers telehealth
- Yes
- Practice phone
- (415) 884-1840
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mark R. Homicz practices at Prima Medical Foundation in Santa Rosa, California
Dr. Homicz's primary practice is Prima Medical Foundation, at 1701 4th St, Santa Rosa, CA 95404 in Sonoma County. The practice phone is (415) 884-1840.
- Prima Medical Foundation1701 4th St, Santa Rosa, CA 95404 · Sonoma CountyPhone(415) 884-1840
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mark R. Homicz is affiliated with 8 sites of care and 2 medical groups
Dr. Homicz's primary practice is Prima Medical Foundation in Santa Rosa, California. Dr. Homicz is also affiliated with Providence Santa Rosa Memorial Hospital. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Homicz to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.
Prima Medical FoundationPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mark R. Homicz's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Homicz practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Prima Medical Foundation | Available with a free account |
| +7 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Homicz practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark R. Homicz is one of 1,107 otolaryngologists in California
Otolaryngology is Dr. Homicz's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Homicz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Homicz is licensed in California.
Specialties and state licenses
- Otolaryngology, CaliforniaPrimary
Clinical focus
Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Homicz treats.
Otolaryngologists near Dr. Homicz
Counts of otolaryngologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark R. Homicz billed Medicare for 1,515 services in 2024
CMS data shows 1,515 Medicare services from Dr. Homicz across 19 procedure codes in 2024, for 509 Medicare patients. Medicare paid $131,848 for them.
Medicare services, 20241,515
Medicare patients509
Paid by Medicare$131,848
Procedure codes19
Dr. Homicz's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,0122024: 86215%
- Surgery
- 2023: 6332024: 49522%
- Tests and treatments
- 2023: 2822024: 11360%
- Other services
- 2023: 382024: 2826%
- Imaging
- 2023: 412024: 1759%
Where Dr. Homicz's Medicare services took place, 2024
- In an office1,46297%
- In a facility533%
Dr. Homicz compared with the California median for otolaryngologists, 2024
- Dr. Homicz
- California median
- Medicare services
- 1,515vs 6662.3 times
- Medicare patients
- 509vs 29672% above
- Part D claims
- 297vs 1182.5 times
Medians across 1,045 otolaryngologists in California with Dmand AI profiles that report each measure.
Dr. Homicz's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Homicz?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Homicz and other otolaryngologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mark R. Homicz treated 509 Medicare patients in 2024, average age 75
CMS counts 509 Medicare patients who saw Dr. Homicz in 2024. The largest group is 75 to 84, with 211 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Homicz's median patient age at 70, with 55% women.
Medicare patients, 2024509
Average age75
Average risk score1.23
Also on Medicaid18%
Dr. Homicz's Medicare patients by age, 2024
Dr. Homicz's Medicare patients by sex, 2024
- Women27855%
- Men23145%
Chronic conditions among Dr. Homicz's Medicare patients, 2024
- High cholesterol73%
- High blood pressure67%
- Arthritis47%
- Ischemic heart disease29%
- Anxiety25%
- Mood disorders22%
- Diabetes20%
- Osteoporosis20%
Share of Medicare patients with each condition. A patient can have several.
Dr. Homicz's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women55%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mark R. Homicz wrote 406 Medicare Part D claims in 2024
In 2024, Dr. Homicz wrote 406 Medicare Part D claims for 179 patients. 93% of them were for generic drugs. CMS names the drug for 297 of them, across 10 drugs with 11 or more claims each, at $3,787 in total drug cost. In 2023, CMS named 331 claims across 11 drugs.
Part D claims, 2024406
Drugs named by CMS10
Total drug cost$3,787
Part D patients179
Dr. Homicz's Part D claims by kind of drug, 2024
- Generic378 claims93%
- Brand-name28 claims7%
Dr. Homicz's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Homicz's Part D claims, 2024
- Opioids14%55 of 406 claims
- Antibiotics10%40 of 406 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3312024: 29710%
Drugs named by CMS: 10 in 2024, 11 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mark R. Homicz scored 81 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Homicz for performance year 2024. CMS lists Dr. Homicz as offering telehealth.
- Offers telehealth
- Yes
Dr. Homicz's MIPS scores, performance year 2024
- 81of 100Final score
- 80.9of 100Quality
- 76of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)
Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Find otolaryngologists like Dr. Homicz by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark R. Homicz has 6 publications on record
Dmand AI links 6 papers to Dr. Homicz. The most frequent topics are Chondrocytes, Nasal Septum and Tissue Engineering. Dr. Homicz's most frequent co-authors are Deborah Watson, MD, Stanley Chia, MD and Daniela Stangenhaus De Carvalho, MD.
Papers6
Topics Dr. Homicz writes about most
- Chondrocytes
- Nasal Septum
- Tissue Engineering
- Alginates
- Cartilage
- Cell Division
- Cells, Cultured
- Collagen
Dr. Homicz's most frequent co-authors
- Deborah Watson, MD4 shared papers
- Stanley Chia, MD2 shared papers
- Daniela Stangenhaus De Carvalho, MD1 shared paper
Recent publications by Dr. Homicz
AlginatesCartilageCell Division
Adipose TissueBiocompatible MaterialsCattle
J Am Coll Surg
AlginatesAnalysis of VarianceCell Differentiation
See who Dr. Homicz researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Homicz works with, so you can find a warm path to the right otolaryngologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark R. Homicz received $2,899 in industry payments from 2016 to 2025
CMS Open Payments shows 97 general payments to Dr. Homicz from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Intersect ENT, Inc. paid the most, $508.
General payments to Dr. Homicz by program year, 2016 to 2025
General payments to Dr. Homicz by kind, 2016 to 2025
$2.9Kin total
- Food and beverage$2,78496%
- Education$993%
- Travel and lodging$161%
Companies that paid Dr. Homicz the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark R. Homicz has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Homicz, most recently Regional Top Doctor in 2014.
Awards and honors for Dr. Homicz
- 2014
- Regional Top Doctor
- Undated
- AAO-HNS Fellow
Source: Dmand AI Professional Profile Data
Dr. Mark R. Homicz graduated from Yale School of Medicine
Dr. Homicz graduated from Yale School of Medicine in 1998. Dr. Homicz is a member of NHS.
- Medical school
- Board certified in otolaryngology
Source: Dmand AI Professional Profile Data
Dr. Mark R. Homicz accepts plans from 9 insurance carriers
Dr. Homicz is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- Blue Cross and Blue Shield of Kansas City
- +1 more carriersWith a free account
Plan types Dr. Homicz accepts, by number of carriers
- Medicare8
- PPO7
- POS4
- EPO3
- HMO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Mark R. Homicz's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark R. Homicz
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark R. Homicz's NPI number?
Dr. Mark R. Homicz's NPI number is 1336198449. It was assigned on May 8, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark R. Homicz?
Dr. Mark R. Homicz is an otolaryngologist in Santa Rosa, California. The primary specialty in the NPI Registry is Otolaryngology Physician (taxonomy code 207Y00000X).
Where does Dr. Mark R. Homicz practice?
Dr. Homicz practices at 1701 4th St, Santa Rosa, CA 95404. Dr. Homicz's primary practice is Prima Medical Foundation in Santa Rosa, California. Dmand AI also links Dr. Homicz to 4 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Mark R. Homicz's office phone number?
The practice phone on file for Dr. Homicz is (415) 884-1840.
What is Dr. Mark R. Homicz's medical license number?
Dr. Homicz holds California license A70413.
Which hospitals is Dr. Mark R. Homicz affiliated with?
Dr. Homicz is affiliated with Providence Santa Rosa Memorial Hospital. Dmand AI links Dr. Homicz to 4 more hospitals.
What medical group is Dr. Mark R. Homicz part of?
Dr. Homicz is linked to UCSF Medical Group. Dmand AI links Dr. Homicz to 1 more medical group.
Does Dr. Mark R. Homicz accept Medicare?
Yes. CMS data shows Dr. Homicz billed Medicare for 1,515 services in 2024.
Does Dr. Mark R. Homicz offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Homicz as offering telehealth services.
What is Dr. Mark R. Homicz's MIPS score?
Dr. Homicz's MIPS final score for performance year 2024 is 81 out of 100.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Mark R. Homicz see?
CMS counts 509 Medicare patients who saw Dr. Homicz in 2024, with an average age of 75.
Is Dr. Mark R. Homicz board certified?
Yes. Dr. Homicz is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery.
What services does Dr. Mark R. Homicz bill to Medicare?
In 2024, Dr. Homicz's most billed Medicare services were office visit, established patient (99213), surgery: ear (69210) and office visit, established patient (99214).
Where did Dr. Mark R. Homicz go to medical school?
Dr. Homicz graduated from Yale School of Medicine in 1998.
What drugs does Dr. Mark R. Homicz prescribe most?
In 2024 Medicare Part D data, Dr. Homicz's most prescribed drugs by claims were Levothyroxine Sodium, Hydrocodone-Acetaminophen and Ipratropium Bromide.
Has Dr. Mark R. Homicz received payments from drug or device companies?
CMS Open Payments shows $2,899 in general payments to Dr. Homicz from 23 companies from 2016 to 2025. The largest total came from Intersect ENT, Inc.
How long has Dr. Mark R. Homicz been practicing?
Dr. Homicz graduated from medical school in 1998, 28 years ago.
Does Dr. Mark R. Homicz do research?
Dmand AI links 6 publications to Dr. Homicz.
Who does Dr. Mark R. Homicz publish with?
Dr. Homicz's most frequent co-authors are Deborah Watson, MD (4 shared papers), Stanley Chia, MD (2 shared papers) and Daniela Stangenhaus De Carvalho, MD (1 shared paper).
What insurance does Dr. Mark R. Homicz accept?
Dr. Homicz is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to otolaryngology practices?
See otolaryngologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card